FrancophonIA/ELRC3.0 huggingface dataset:
English: Animals should not be stroked, groomed or allow to groom each other, until the application site is dry, and they should not be allowed to swim or treated with shampoo within 48 hours after treatment.
Estonian: Kui ravim on loomale manustatud, ei tohi looma silitada, kammida ega lasta teisel loomal puutuda, enne kui manustamiskoht on kuiv, samuti ei tohi lasta loomal ujuda ega pesta looma šampooniga 48 tunni jooksul pärast ravimi manustamist.
English: The effectiveness against the specified parasites was investigated in both laboratory studies and in five field studies (four for the spot-on for cats or dogs only and one for both cats and dogs).
Estonian: Ravimi efektiivsust näidustatud parasiitide vastu uuriti laboriuuringutes ja viies väliuuringus (neli kasside või koerte täpilahuse uuringut ja üks nii kassidel kui ka koertel).
English: Why has Activyl been approved?
Estonian: Miks Activyl heaks kiideti?
English: In the main field study, dogs and cats of various breeds, age groups, gender and different weights were treated either with Activyl or fipronil, another spot-on medicine which is authorised in the European Union for this indication.
Estonian: Põhilises väliuuringus raviti eri tõust, vanuserühmast, soost ja kehakaaluga loomi kas Activyli või teise täpiravimi fiproniiliga, millel on Euroopa Liidus selle näidustuse raviks müügiluba.
English: Pet owners should avoid skin contact with the pipette contents.
Estonian: Loomaomanikud peavad vältima pipeti sisu sattumist nahale.
English: What is the risk associated with Activyl?
Estonian: Mis riskid Activyliga kaasnevad?
English: Activyl is given as a single treatment.
Estonian: Activyli kasutatakse ühekordseks raviks.
English: Activyl is a medicine that contains the active substance indoxacarb.
Estonian: Activyl on ravim, mis sisaldab toimeainena indoksakarbi.
English: The results from the laboratory studies and from the field studies, in both cats and dogs, showed that Activyl is as effective as the comparator medicine.
Estonian: Nii kasside kui ka koertega korraldatud labori- ja väliuuringute tulemused näitasid, et Activyl on sama efektiivne kui võrdlusravim.
English: Furthermore, the CVMP concluded that the product is effective as part of a treatment strategy for flea allergy dermatitis and recommended that Activyl be given a marketing authorisation.
Estonian: Veterinaarravimite komitee järeldas ka, et ravim on efektiivne kirbuallergiast tingitud dermatiidi ravi osana, ja soovitas anda Activyli müügiloa.
English: Care should be taken to ensure that the content of the pipette should not come into contact with the eyes of the recipient or other animals.
Estonian: Ravimi manustamisel tuleb olla ettevaatlik, et ravimit ei satuks ravitava looma ega teiste loomade silma.
English: Data were provided on the pharmaceutical quality, the tolerance of the products in cats and dogs, the safety in humans (people in contact with the product) and the safety to the environment.
Estonian: Esitati ravimi farmatseutilise kvaliteedi, koerte ja kasside ravimitaluvuse, ravimiga kokku puutuvate inimeste ohutuse ja keskkonnaohutuse andmed.
English: Other information about Activyl:
Estonian: Muu teave Activyli kohta
English: The product should be kept away from heat, sparks, open flames or other sources of ignition.
Estonian: Ravimit tuleb kaitsta soojuse, sädemete, lahtise leegi ja muude süttimisallikate eest.
English: If accidental exposure occurs, the eyes should be rinsed with water or the skin washed with soap and water.
Estonian: Silma sattumisel tuleb silmi loputada veega ning nahale sattumisel pesta nahka vee ja seebiga.
English: For a full list of all side-effects reported with Activyl, see the package leaflet.
Estonian: Activyli kohta teatatud kõrvalnähtude täielik loetelu on pakendi infolehel.
English: The studies also showed that Activyl helps with the management of allergic flea dermatitis.
Estonian: Uuringutes selgus ka, et Activyl leevendab kribuallergiast põhjustatud dermatiiti.
English: The contents of one full Activyl pipette (appropriate to the animal and its weight) is applied directly to the skin, after parting the animals fur, onto the back of the cat's neck at the base of its head, or between the shoulder blades and along the back of dogs.
Estonian: Activyli ühe täispipeti sisu (loomale ja kehakaalule sobiv) tilgutatakse otse kukla all kassi kaelanahale, tõmmates karvad laiali, või koeral abaluude vahele ja piki selga.
English: Activyl is used to treat and prevent flea infestations in dogs and cats and to treat flea allergy dermatitis (an allergic reaction to flea bites).
Estonian: Activyli kasutatakse koertel ja kassidel kirpude hävitamiseks ja tõrjeks ning kirbuallergiast põhjustatud dermatiidi (allergiline reaktsioon kirbuhammustustele) raviks.
English: The effectiveness was measured by counting of fleas, flea allergy dermatitis assessment, observations on local reactions at the application site after treatment.
Estonian: Efektiivsuse põhinäitaja oli elusate kirpude arv, kirbuallergiast põhjustatud dermatiidi hinnang ja manustamiskohal pärast ravi täheldatud paiksed reaktsioonid.
English: This means that it will kill parasites that live on the skin or in the fur of animals, such as fleas.
Estonian: Välisparasiidid on parasiidid, kes elavad looma nahal või karvastikus, näiteks kirbud.
English: It is available as a clear, colourless to yellow solution presented as a ‘spot-on' in pipettes already filled with the correct amount of Activyl needed to treat one cat or dog depending on its weight (5 sizes of pipettes for different dog weights and 2 sizes of pipettes for different cat weights).
Estonian: Seda turustatakse läbipaistva värvitu kuni kollase täpilahusega eeltäidetud pipettides, st väikeses plastmahutis, milles on ühe kassi või koera ravimiseks vajalik Activyli kogus, olenevalt looma kehakaalust (5 pipetisuurust koertele ja 2 suurust kassidele).
English: What benefit has Activyl shown during the studies?
Estonian: Milles seisneb uuringute põhjal Activyli kasulikkus?
English: What is Activyl used for?
Estonian: Milleks Activyli kasutatakse?
English: There might also be some temporary itchiness, inflammation or hair loss at the place where the product has been applied to the skin.
Estonian: Võib esineda ka manustamiskoha ajutist sügelust, põletikku või karvade väljalangemist.
English: How has Activyl been studied?
Estonian: Kuidas Activyli uuriti?
English: The CVMP concluded that the benefits of Activyl exceed the risks for the treatment and prevention of flea infestations in dogs and cats.
Estonian: Veterinaarravimite komitee jõudis järeldusele, et Activyli kasulikkus koertel ja kassidel kirpude ja hävitamiseks ja tõrjeks on suurem kui sellega kaasnevad riskid.
English: A reduction in symptoms of flea allergy dermatitis was recorded in both target species.
Estonian: Mõlemal sihtliigil leevenesid kirbuallergiast põhjustatud dermatiidi nähud.
English: Dogs and cats might salivate after treatment.
Estonian: Koertel ja kassidel võib pärast ravi esineda süljevoolust, mille arvatav põhjus on see, et loom lakub vahetult pärast ravimi manustamist manustamiskohta.
English: How does Activyl work?
Estonian: Kuidas Activyl toimib?
English: The active substance in Activyl, indoxacarb, is an ectoparasiticide.
Estonian: Activyli toimeaine indoksakarb on ektoparasitiitsiid ehk välisparasiitide vastane aine.
English: After application, indoxacarb is eaten by the insects and activated in their gut into an active compound.
Estonian: Manustatud indoksakarb satub putukate seedekulglasse, kus muutub aktiivseks toimeaineks.
English: They should not smoke, eat or drink, and should wash their hands thoroughly after use.
Estonian: Ravimi manustamisel ei tohi suitsetada, süüa ega juua ning pärast ravimi manustamist tuleb pesta hoolikalt käsi.
English: These combinations are not covered in this summary.
Estonian: Käesolev kokkuvõte ei hõlma selliseid kombinatsioone.
English: This means that, although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years (including at least 15 years within the EU).
Estonian: See tähendab, et kuigi nende taimsete ravimite kohta ei ole piisavalt kliiniliste uuringute andmeid, on nende efektiivsus tõenäoline ja on olemas andmed selle kohta, et neid on sellisel viisil ohutult kasutatud vähemalt 30 aastat (sealjuures Euroopa Liidus vähemalt 15 aastat).
English: Guarana seed
Estonian: Guaraana
English: The plant is cultivated or gathered to obtain the seeds for medicinal use.
Estonian: Taime kasvatatakse või korjatakse, et saada seemneid meditsiiniliseks kasutamiseks.
English: If symptoms persist for longer than one week during the use of Guarana seed, a qualified healthcare practitioner should be consulted.
Estonian: Kui sümptomid püsivad guaraana kasutamisel üle ühe nädala, tuleb pöörduda pädeva tervishoiutöötaja poole.
English: Paulinia cupana Kunth ex H.B.K.
Estonian: Paullinia cupana Kunth ex H.B.K.
English: Guarana seed should only be used in adults.
Estonian: Guaraanat tohib kasutada üksnes täiskasvanutel.
English: What is guarana seed?
Estonian: Mis on guaraana?
English: Guarana seed EMA/HMPC/284498/2013
Estonian: Guaraana EMA/HMPC/284498/2013
English: The HMPC recommended that these medicines should not be used in patients with stomach and gut ulcers, hyperthyroidism (overactive thyroid gland) or cardiovascular problems, such as hypertension (high blood pressure) and arrhythmias (heart rhythm problems).
Estonian: Taimsete ravimite komitee soovituse kohaselt ei tohi guaraanat kasutada patsiendid, kellel on mao- või soolehaavandid, hüpertüreoidism (kilpnäärme ületalitlus) või sellised südame-veresoonkonna probleemid nagu hüpertooniatõbi (kõrge vererõhk) või arütmiad (südame rütmihäired).
English: Detailed instructions on how to take guarana seed medicines and who can use them can be found in the package leaflet that comes with the medicine.
Estonian: Täpsed juhised , kuidas guaraanat sisaldavaid ravimeid võtta ja kes tohivad neid kasutada, on kirjas ravimi pakendi infolehes.
English: Further information on the HMPC assessment of guarana seed medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Estonian: Lisateave guaraanat sisaldava ravimi hinnangu kohta, sealhulgas komitee järelduste detailne kirjeldus, on Euroopa Ravimiameti veebilehe jaotises „All documents”: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Other information about guarana seed medicines
Estonian: Muu teave guaraanat sisaldava ravimi kohta
English: Further information on the risks associated with guarana seed medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Estonian: Lisateave guaraanat sisaldava ravimiga kaasnevate riskide, sh ettevaatusabinõude kohta selle ohutuks kasutamiseks, on kirjas taime monograafias Euroopa Ravimiameti veebilehe jaotises „All documents”: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Any applications for the licensing of medicines containing guarana seed have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Estonian: Guaraanat sisaldava ravimi müügiloa taotlus tuleb esitada riiklikule ravimiametile, mis hindab taimse ravimi müügiloa taotlust, võttes arvesse taimsete ravimite komitee teaduslikke järeldusi.
English: The HMPC concluded that, on the basis of its long-standing use, guarana seed can be used for the relief of symptoms of fatigue (tiredness) and weakness.
Estonian: Taimsete ravimite komitee jõudis järeldusele, et guaraana pikaaegsest kasutamisest lähtuvalt võib seda kasutada kurnatuse (väsimuse) ja nõrkuse sümptomite leevendamiseks.
English: The HMPC conclusions on the use of guarana seed medicines for fatigue and weakness are based on their ‘traditional use'.
Estonian: Taimsete ravimite komitee järeldused guaraanat sisaldavate ravimite kasutamise kohta kurnatuse ja nõrkuse korral põhinevad nende traditsioonilisel kasutusel.
English: EMA/HMPC/284498/2013
Estonian: EMA/HMPC/284498/2013 Taimsete ravimite komitee (HMPC)
English: What evidence supports the use of guarana seed medicines?
Estonian: Millised tõendid toetavad guaraanat sisaldava ravimi kasutamist?
English: Guarana seed preparations are obtained by drying and powdering the seeds.
Estonian: Guaraana tooteid saadakse seemnete kuivatamisel ja pulbristamisel.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of guarana seed.
Estonian: See on taimsete ravimite komitee teaduslike järelduste kokkuvõte, mis käsitleb guaraana meditsiinilisi kasutusviise.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing guarana seed.
Estonian: ELi liikmesriigid võtavad taimsete ravimite komitee järeldusi arvesse, kui nad hindavad guaraanatt sisaldavate taimsete ravimite müügilubade taotlusi.
English: Guarana seed is the common name for the seed of the plant Paulinia cupana Kunth ex H.B.K.
Estonian: Guaraana on taime Paullinia cupana Kunth ex H.B.K.
English: Herbal medicines containing guarana seed are usually available in solid forms to be taken by mouth.
Estonian: Guaraanat sisaldavaid taimseid ravimeid turustatakse tavaliselt tahkete ravimvormidena suukaudseks manustamiseks.
English: What are the risks associated with guarana seed medicines?
Estonian: Mis riskid kaasnevad guaraanat sisaldava ravimiga?
English: var. sorbilis (Mart.) Ducke.
Estonian: var. sorbilis (Mart.) Ducke (guaraana-pauliinia) seemnete üldnimetus.
English: How are guarana seed medicines approved in the EU?
Estonian: Kuidas antakse Euroopa Liidus guaraanat sisaldavale ravimile müügiluba?
English: Guarana seed can also be found in combination with other herbal substances in some herbal medicines.
Estonian: Mõnes taimses ravimis esineb guaraana koos teiste taimsete ainetega.
English: For more information about treatment with guarana seed medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Estonian: Kui vajate lisateavet guaraanat sisaldava ravimi kasutamise kohta, lugege palun pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: For practical information about using guarana seed medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Estonian: Kui vajate guaraanat sisaldava ravimi kasutamise kohta praktilisi nõuandeid, lugege ravimi pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: Information on the use and licensing of guarana seed medicines in EU Member States should be obtained from the relevant national authorities.
Estonian: ELi liikmesriikides saab teavet guaraanat sisaldava ravimi kasutamise ja müügiloa kohta riiklikult ravimiametilt.
English: This summary is not intended to provide practical advice on how to use medicines containing guarana seed.
Estonian: Kokkuvõttes ei anta guaraanat sisaldava ravimi kasutamise kohta praktilisi nõuandeid.
English: In its assessment, the HMPC considered studies on the effects of guarana seed on behaviour, which showed that it had a stimulant effect and led to improvements in symptoms of fatigue.
Estonian: Taimsete ravimite komitee vaatles hindamisel uuringuid, mis käsitlevad guaraana mõju käitumisele.
English: Intravenous use vial (plastic)
Estonian: Intravenoosne viaal (plast)
English: --1 Cell-associated live recombinant turkey herpesvirus expressing the fusion protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus: 103.3 - 104.6 PFU* * PFU: plaque forming units.
Estonian: -1 Elus lindude infektsioosse bronhiidi viiruse tüve D388 104, 0 - 105,5 EID50
English: Invented name Strength Pharmaceutical form
Estonian: Tugevus Ravimvorm Loomaliigid Manustamisviis Pakend Sisaldus Pakendi suurus
English: EU Number
Estonian: EL (ML) number Väljamõeldud nimetus
English: Target species
Estonian: 10 topsi
English: This depends on the patient's response and requirements (e.g. diet, physical activity and life-style).
Estonian: See sõltub patsiendi ravivastusest ja vajadustest (näiteks dieet, füüsiline aktiivsus ja eluviis).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Exubera on 24 January 2006.
Estonian: Euroopa Komisjon väljastas Exubera müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 24. jaanuaril 2006.
English: Smokers must have stopped smoking for at least 6 month before they can take Exubera.
Estonian: Suitsetajad peavad olema suitsetamise lõpetanud vähemalt 6 kuud enne Exubera manustamist.
English: Exubera is given within 10 minutes before the start of a meal.
Estonian: Exuberat manustatakse 10 minutit enne söömist.
English: Patients must not smoke while taking Exubera.
Estonian: Patsiendid ei tohi Exubera kasutamise ajal suitsetada.
English: Patients with poor or unstable lung function, such as asthma, emphysema or chronic bronchitis, should not use Exubera.
Estonian: Halva või ebastabiilse kopsufunktsiooniga patsiendid, kellel näiteks on astma, emfüseem või krooniline bronhiit, ei tohi Exuberat kasutada.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) EXUBERA EPAR summary for the public
Estonian: EUROOPA AVALIK HINDAMISARUANNE EXUBERA Kokkuvõte üldsusele
English: So Exubera is not suitable when small (less than 3 IU) adjustments of insulin are necessary (for example in patient with low body weight).
Estonian: Exubera ei sobi, kui kohandatavad insuliiniannused on väikesed (alla 3 RÜ) (näiteks väikese kehakaaluga patsientidel).
English: Before starting Exubera, a doctor or a nurse must explain to the patient how to use the inhaler properly to minimise risk and ensure that the patient gets the best benefit from their treatment.
Estonian: Enne Exubera kasutamise alustamist peab arst või õde patsiendile selgitama, kuidas ohtude vähendamiseks ja parima ravitoime saavutamiseks inhalaatorit õigesti kasutada.
English: Three 1 mg doses should not be used instead of one 3 mg dose because this gives a higher insulin dose and may increase the risk of hypoglycaemia.
Estonian: Ühe 3 mg annuse asemel ei tohi kasutada kolme 1 mg annust, sest nii saadakse suurem insuliiniannus ja see võib suurendada hüpoglükeemia tekke ohtu.
English: If a patient already has lung disease, it is not clear how the use of Exubera affects their lungs or how the lung disease affects the intake of insulin from the lungs.
Estonian: Kui patsiendil juba on kopsuhaigus, ei ole selge, kuidas Exubera kasutamine mõjustab tema kopse või kui palju mõjustab kopsuhaigus insuliini imendumist kopsudest.
English: The most common side effects of Exubera are hypoglycaemia (low blood glucose) and cough.
Estonian: Kõige sagedamad Exubera kõrvalnähud on hüpoglükeemia (vere vähene glükoosisisaldus) ja köha.
English: The company that makes Exubera will carry out studies to further test its safety, particularly in patients who might have an increased risk of side effects, such as patients with asthma or chronic obstructive pulmonary disease.
Estonian: Exubera tootja teeb ravimi ohutuse kontrollimiseks lisauuringuid, eriti nende patsientide puhul, kellel on suurem kõrvalnähtude tekke oht, näiteks astma või kroonilise obstruktiivse kopsuhaigusega patsiendid.
English: If a patient smokes, the amount of insulin that is absorbed from the lungs greatly increases and this may increase the risk of hypoglycaemia.
Estonian: Kui patsient suitsetab, siis suureneb oluliselt kopsudest imenduva insuliini hulk ja see võib suurendada hüpoglükeemia tekke ohtu.
English: A doctor decides for each patient the starting doses and the timing of the doses, and the dose adjustment schedule.
Estonian: Arst määrab igale patsiendile algannused, annuste kasutamise aja ja kohandamise kava.
English: By controlling the level of blood sugar, the symptoms and complications of diabetes are reduced.
Estonian: Veresuhkru taseme reguleerimise kaudu vähenevad suhkurtõve sümptomid ja tüsistused.
English: The insulin in Exubera is produced by a method known as ‘recombinant DNA technology' which means that the insulin is made by a bacterium which has received a gene (DNA) that makes it able to produce the insulin.
Estonian: Exuberas olevat insuliini toodetakse rekombinant-DNA-tehnikaks nimetataval meetodil, kus insuliini toodavad bakterid, millesse on viidud geen (DNA), mis annab neile insuliini tootmise võime.
English: Exubera contains 1 mg or 3 mg of
Estonian: Exubera sisaldab 1 mg või 3 mg toimeainet iniminsuliini.
English: Diabetes is a disease in which the body does not produce enough insulin to control the level of blood sugar.
Estonian: Suhkurtõbi on haigus, mille korral keha ei tooda veresuhkru taseme kontrolli all hoidmiseks piisavalt insuliini.
English: The studies measured the level in the blood of glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Estonian: Uuringute käigus mõõdeti glükoosiga seostunud hemoglobiini (HbA1c) sisaldust veres, mis näitab, kui hästi reguleerib organism vere glükoosisisaldust.
English: They will also look at the development of insulin antibodies (proteins that are produced in response to treatment with Exubera).
Estonian: Uuritakse ka insuliinivastaste antikehade teket (valgud, mis tekivad vastuseks ravile Exuberaga).
English: Exubera is used only with its insulin inhaler.
Estonian: Exuberat kasutatakse vaid koos insuliini inhalaatoriga.
English: The Committee for Medicinal products for Human Use (CHMP) decided that Exubera's benefits are greater than its risks in certain adult patients with diabetes when used as described in the Product information, and recommended that Exubera be given marketing authorisation.
Estonian: Inimtervishoius kasutatavate ravimite komitee jõudis otsusele, et Exubera kasulikkus ületab ravimi kasutamisega seotud ohud, kui ravimit kasutatakse teatud täiskasvanud patsientidel, kellel on suhkurtõbi, vastavalt ravimi kirjeldusele, ning soovitas anda Exuberale müügiloa.
English: During the studies, Exubera showed a small negative effect on lung function that may disappear when Exubera is stopped.
Estonian: Uuringute ajal leiti Exuberal vähene negatiivne toime kopsude talitlusele, mis võib kaduda pärast Exuberaga ravi lõpetamist.
English: Exubera should not be used in people who may be hypersensitive (allergic) to human insulin or any of
Estonian: Exuberat ei tohi kasutada patsiendid, kes võivad olla ülitundlikud (allergilised) iniminsuliini või ravimi mis tahes muu koostisosa suhtes.
English: What is the risk associated with Exubera?
Estonian: Millised on Exuberaga kaasnevad riskid?
English: When inhaled, some of the insulin is absorbed into the blood (the rest is broken down in the lungs).
Estonian: Sissehingamisel imendub osa insuliinist verre (ülejäänud laguneb kopsudes).
English: If a patient starts or resumes smoking when treated with Exubera, they must use another anti-diabetic treatment immediately.
Estonian: Kui patsient alustab või jätkab suitsetamist Exubera kasutamise ajal, peab ta kasutama ka muid suhkurtõveravimeid.
English: How has Exubera been studied?
Estonian: Kuidas Exuberat uuriti?
English: Exubera can also be used for certain adults with type 1 diabetes, who can benefit from replacing fast-acting subcutaneous insulin by this inhaled insulin, taking into
Estonian: Exuberat võib kasutada ka teatud I tüüpi suhkurtõvega täiskasvanud patsientidel, kes võivad saada kasu lühitoimelise nahaaluse insuliini asendamisest kõnealuse sissehingatava insuliiniga, võttes seejuures arvesse ka võimalikke ohte.
English: To take a dose, the patient places the blister in the inhaler, and inhales it through the mouth into the lungs.
Estonian: Annuse sissevõtmiseks asetab patsient blisterpakendi inhalaatorisse ja hingab läbi suu sügavasti sisse.